328 related articles for article (PubMed ID: 9353252)
1. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo.
Chin L; Pomerantz J; Polsky D; Jacobson M; Cohen C; Cordon-Cardo C; Horner JW; DePinho RA
Genes Dev; 1997 Nov; 11(21):2822-34. PubMed ID: 9353252
[TBL] [Abstract][Full Text] [Related]
2. Dual inactivation of RB and p53 pathways in RAS-induced melanomas.
Bardeesy N; Bastian BC; Hezel A; Pinkel D; DePinho RA; Chin L
Mol Cell Biol; 2001 Mar; 21(6):2144-53. PubMed ID: 11238948
[TBL] [Abstract][Full Text] [Related]
3. Somatic p16(INK4a) loss accelerates melanomagenesis.
Monahan KB; Rozenberg GI; Krishnamurthy J; Johnson SM; Liu W; Bradford MK; Horner J; Depinho RA; Sharpless NE
Oncogene; 2010 Oct; 29(43):5809-17. PubMed ID: 20697345
[TBL] [Abstract][Full Text] [Related]
4. Genetic dissection of melanoma pathways in the mouse.
Yang FC; Merlino G; Chin L
Semin Cancer Biol; 2001 Jun; 11(3):261-8. PubMed ID: 11407950
[TBL] [Abstract][Full Text] [Related]
5. Induction of melanoma in murine macrophage inflammatory protein 2 transgenic mice heterozygous for inhibitor of kinase/alternate reading frame.
Yang J; Luan J; Yu Y; Li C; DePinho RA; Chin L; Richmond A
Cancer Res; 2001 Nov; 61(22):8150-7. PubMed ID: 11719444
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
Edmunds SC; Kelsell DP; Hungerford JL; Cree IA
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501
[TBL] [Abstract][Full Text] [Related]
7. p16/CDKN2 and CDK4 gene mutations in sporadic melanoma development and progression.
Piccinin S; Doglioni C; Maestro R; Vukosavljevic T; Gasparotto D; D'Orazi C; Boiocchi M
Int J Cancer; 1997 Feb; 74(1):26-30. PubMed ID: 9036865
[TBL] [Abstract][Full Text] [Related]
8. High frequency of p16(INK4A) promoter methylation in NRAS-mutated cutaneous melanoma.
Jonsson A; Tuominen R; Grafström E; Hansson J; Egyhazi S
J Invest Dermatol; 2010 Dec; 130(12):2809-17. PubMed ID: 20703244
[TBL] [Abstract][Full Text] [Related]
9. Loss of xeroderma pigmentosum C (Xpc) enhances melanoma photocarcinogenesis in Ink4a-Arf-deficient mice.
Yang G; Curley D; Bosenberg MW; Tsao H
Cancer Res; 2007 Jun; 67(12):5649-57. PubMed ID: 17575131
[TBL] [Abstract][Full Text] [Related]
10. Low prevalence of p53, p16(INK4a) and Ha-ras tumour-specific mutations in low-graded actinic keratosis.
Nindl I; Gottschling M; Krawtchenko N; Lehmann MD; Röwert-Huber J; Eberle J; Stockfleth E; Forschner T
Br J Dermatol; 2007 May; 156 Suppl 3():34-9. PubMed ID: 17488404
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the Ink4a gene (p16 and p19arf) in murine tumorigenesis.
Orlow I; Rabbani F; Chin L; Pomerantz J; Ligeois N; Dudas M; Depinho R; Cordón-Cardó C
Int J Oncol; 1999 Jul; 15(1):17-24. PubMed ID: 10375589
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous uveal amelanotic melanoma in transgenic Tyr-RAS+ Ink4a/Arf-/- mice.
Tolleson WH; Doss JC; Latendresse J; Warbritton AR; Melchior WB; Chin L; Dubielzig RR; Albert DM
Arch Ophthalmol; 2005 Aug; 123(8):1088-94. PubMed ID: 16087843
[TBL] [Abstract][Full Text] [Related]
13. The latent membrane protein 1 of Epstein-Barr virus and loss of the INK4a locus: paradoxes resolve to cooperation in carcinogenesis in vivo.
Macdiarmid J; Stevenson D; Campbell DH; Wilson JB
Carcinogenesis; 2003 Jul; 24(7):1209-18. PubMed ID: 12807717
[TBL] [Abstract][Full Text] [Related]
14. Genetic Alterations in the INK4a/ARF Locus: Effects on Melanoma Development and Progression.
Ming Z; Lim SY; Rizos H
Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33076392
[TBL] [Abstract][Full Text] [Related]
15. Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background.
Ackermann J; Frutschi M; Kaloulis K; McKee T; Trumpp A; Beermann F
Cancer Res; 2005 May; 65(10):4005-11. PubMed ID: 15899789
[TBL] [Abstract][Full Text] [Related]
16. Genes involved in melanoma: an overview of INK4a and other loci.
Castellano M; Parmiani G
Melanoma Res; 1999 Oct; 9(5):421-32. PubMed ID: 10596908
[TBL] [Abstract][Full Text] [Related]
17. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.
Wang Y; Zhang Z; Kastens E; Lubet RA; You M
Cancer Res; 2003 Aug; 63(15):4389-95. PubMed ID: 12907609
[TBL] [Abstract][Full Text] [Related]
18. [The INK4a-ARF locus: role in the genetic predisposition to familial melanoma and in skin carcinogenesis].
Soufir N; Basset-Seguin N
Bull Cancer; 2001 Nov; 88(11):1061-7. PubMed ID: 11741799
[TBL] [Abstract][Full Text] [Related]
19. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation.
Smeds J; Berggren P; Ma X; Xu Z; Hemminki K; Kumar R
Carcinogenesis; 2002 Apr; 23(4):645-55. PubMed ID: 11960918
[TBL] [Abstract][Full Text] [Related]
20. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice.
Krimpenfort P; Quon KC; Mooi WJ; Loonstra A; Berns A
Nature; 2001 Sep; 413(6851):83-6. PubMed ID: 11544530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
